ConductScience.org, home

Paper17599165

Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

Lieberman JA. Prim Care Companion J Clin Psychiatry, 2007. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Papers, record 17599165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599165

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
PubMed
Journal
Prim Care Companion J Clin Psychiatry
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2020-09-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lieberman JAJoseph A

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,143,886Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.J Int Med Res1993https://conductscience.org/library/papers/8143886PubMed
215,649,738Melatonin as a hypnotic: pro.Sleep Med Rev2005https://conductscience.org/library/papers/15649738PubMed
37,984,354Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.Neurosci Biobehav Rev1994https://conductscience.org/library/papers/7984354PubMed
416,815,744Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.Sleep Med2006https://conductscience.org/library/papers/16815744PubMed
56,133,538The use of short- and long-acting hypnotics in clinical medicine.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6133538PubMed
611,465,523Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.J Clin Psychiatry2001https://conductscience.org/library/papers/11465523PubMed
710,548,105Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.Nature1999https://conductscience.org/library/papers/10548105PubMed
87,525,193Guidelines for the rational use of benzodiazepines. When and what to use.Drugs1994https://conductscience.org/library/papers/7525193PubMed
9430,730Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.JAMA1979https://conductscience.org/library/papers/430730PubMed
107,140,142Quazepam and flurazepam: long-term use and extended withdrawal.Clin Pharmacol Ther1982https://conductscience.org/library/papers/7140142PubMed
1115,226,287Treatment of primary insomnia.J Am Board Fam Pract2004https://conductscience.org/library/papers/15226287PubMed
122,391,399Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children.J Clin Pharmacol1990https://conductscience.org/library/papers/2391399PubMed
1310,211,871Zaleplon pharmacokinetics and absolute bioavailability.Biopharm Drug Dispos1999https://conductscience.org/library/papers/10211871PubMed
1410,682,226Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.Clin Neuropharmacol2000https://conductscience.org/library/papers/10682226PubMed
1516,444,900Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes.Neural Plast2005https://conductscience.org/library/papers/16444900PubMed
168,071,269A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.J Clin Psychiatry1994https://conductscience.org/library/papers/8071269PubMed
1716,477,959A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.Sleep2005https://conductscience.org/library/papers/16477959PubMed
1812,531,146Epidemiology of insomnia: what we know and what we still need to learn.Sleep Med Rev2002https://conductscience.org/library/papers/12531146PubMed
1910,582,735H1-receptor antagonists: safety issues.Ann Allergy Asthma Immunol1999https://conductscience.org/library/papers/10582735PubMed
2015,680,290An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.Sleep Med2005https://conductscience.org/library/papers/15680290PubMed

See all 54 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
39,115,347Effects of a Triage Checklist to optimize insomnia treatment outcomes and reduce hypnotic use: the RCT of the effectiveness of stepped-care sleep therapy in general practice study.Sleep2025https://conductscience.org/library/papers/39115347PubMed
38,321,804Is there a better way to wean chronic benzodiazepine receptor agonists use by substituting a DORA (and starting CBT-I)?J Clin Sleep Med2024https://conductscience.org/library/papers/38321804PubMed
38,288,131
Developing, validating, and comparing an analytical method to simultaneously detect z-drugs in urine samples using the QuEChERS approach with both liquid chromatography and gas chromatography-tandem mass spectrometry.
Saudi Pharm J2024https://conductscience.org/library/papers/38288131PubMed
38,131,058Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Ment Health Clin2023https://conductscience.org/library/papers/38131058PubMed
30,002,617The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases.Front Mol Neurosci2018https://conductscience.org/library/papers/30002617PubMed
28,584,913Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study.J Neurol2017https://conductscience.org/library/papers/28584913PubMed
25,984,284Persistent psychosis after abuse of high dose of zolpidem.Addict Health2014https://conductscience.org/library/papers/25984284PubMed
25,372,144Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope.PLoS One2014https://conductscience.org/library/papers/25372144PubMed
23,620,678An approach to long-term sedative-hypnotic use.Nat Sci Sleep2012https://conductscience.org/library/papers/23620678PubMed
23,114,457Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.Eur J Clin Pharmacol2013https://conductscience.org/library/papers/23114457PubMed
22,560,522Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study.Mayo Clin Proc2012https://conductscience.org/library/papers/22560522PubMed
22,549,286Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22549286PubMed
21,494,350Adverse reactions to zolpidem: case reports and a review of the literature.Prim Care Companion J Clin Psychiatry2010https://conductscience.org/library/papers/21494350PubMed
19,169,658[Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007].Nervenarzt2009https://conductscience.org/library/papers/19169658PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17599165

GET https://conductscience.org/api/papers/v1/17599165/references?page=2